Myositis-associated interstitial lung disease: predictors of failure of conventional treatment and response to tacrolimus in a US cohort

N Sharma, MS Putman, R Vij, ME Strek… - The Journal of …, 2017 - jrheum.org
Objective. Patients with myositis-associated interstitial lung disease (MA-ILD) are often
refractory to conventional treatment, and predicting their response to therapy is challenging …

Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort.

N Sharma, MS Putman, R Vij, ME Strek… - The Journal of …, 2017 - europepmc.org
Objective Patients with myositis-associated interstitial lung disease (MA-ILD) are often
refractory to conventional treatment, and predicting their response to therapy is challenging …

[PDF][PDF] Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort

N Sharma, MS Putman, R Vij, ME Strek… - The Journal of …, 2017 - academia.edu
Objective. Patients with myositis-associated interstitial lung disease (MA-ILD) are often
refractory to conventional treatment, and predicting their response to therapy is challenging …

Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort

N Sharma, MS Putman, R Vij, ME Strek… - The Journal of …, 2017 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objective.</jats: title>< jats: p> Patients with myositis-associated
interstitial lung disease (MA-ILD) are often refractory to conventional treatment, and …

Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort

N Sharma, MS Putman, R Vij… - The Journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Objective Patients with myositis-associated interstitial lung disease (MA-ILD) are often
refractory to conventional treatment, and predicting their response to therapy is challenging …

Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort

N Sharma, MS Putman, R Vij… - Journal of …, 2017 - scholars.northwestern.edu
Objective: Patients with myositis-associated interstitial lung disease (MA-ILD) are often
refractory to conventional treatment, and predicting their response to therapy is challenging …

Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort

N Sharma, MS Putman, R Vij, ME Strek… - The Journal of …, 2017 - jrheum.org
Objective. Patients with myositis-associated interstitial lung disease (MA-ILD) are often
refractory to conventional treatment, and predicting their response to therapy is challenging …